UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027109
Receipt number R000030893
Scientific Title Evaluation of measurement performance of ophthalmic instruments with crystalline lens opacity
Date of disclosure of the study information 2017/05/15
Last modified on 2020/03/19 20:17:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of measurement performance of ophthalmic instruments with crystalline lens opacity

Acronym

Evaluation of performance of ophthalmic instruments with lens opacity

Scientific Title

Evaluation of measurement performance of ophthalmic instruments with crystalline lens opacity

Scientific Title:Acronym

Evaluation of performance of ophthalmic instruments with lens opacity

Region

Japan


Condition

Condition

Cataract

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluating the performance of several autorefractometers for measuring cataractous eyes.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluating the performance of several autorefractometers for measuring cataractous eyes

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Comparison of results between the developint instrument and three instruments certified in the Pharmaceutical Affairs Law

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Cataract patients

Key exclusion criteria

Patients with retinal disease

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Tetsuro
Middle name
Last name Oshika

Organization

University of Tsukuba

Division name

Faculty of Medicine

Zip code

305-8575

Address

1-1-1 Tennoudai, Tsukuba, Ibaraki, Japan

TEL

0298533148

Email

oshika@eye.ac


Public contact

Name of contact person

1st name Toshifumi
Middle name
Last name Mihashi

Organization

University of Tsukuba

Division name

Faculty of Medicine

Zip code

305-8575

Address

1-1-1 Tennoudai, Tsukuba, Ibaraki, Japan

TEL

0298533148

Homepage URL


Email

mihashi@md.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Topcon Coporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Topcon Coporation

Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Tsukuba

Address

1-1-1 Tennodai, Tsukuba

Tel

0298533148

Email

mihashi@md.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

筑波大学病院


Other administrative information

Date of disclosure of the study information

2017 Year 05 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 04 Month 15 Day

Date of IRB

2017 Year 04 Month 28 Day

Anticipated trial start date

2017 Year 05 Month 15 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry

2018 Year 03 Month 31 Day

Date trial data considered complete

2018 Year 03 Month 31 Day

Date analysis concluded

2018 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 04 Month 24 Day

Last modified on

2020 Year 03 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030893


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name